Cargando…

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland

BACKGROUND: Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Afric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginindza, Themba G., Sartorius, Benn, Dlamini, Xolisile, Östensson, Ellinor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439687/
https://www.ncbi.nlm.nih.gov/pubmed/28531205
http://dx.doi.org/10.1371/journal.pone.0177762
_version_ 1783237971127828480
author Ginindza, Themba G.
Sartorius, Benn
Dlamini, Xolisile
Östensson, Ellinor
author_facet Ginindza, Themba G.
Sartorius, Benn
Dlamini, Xolisile
Östensson, Ellinor
author_sort Ginindza, Themba G.
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland. Cost analysis is critical in providing useful information for economic evaluations to guide policymakers concerned with the allocation of resources in order to reduce the disease burden. MATERIALS AND METHODS: A prevalence-based cost of illness (COI) methodology was used to investigate the economic burden of HPV-related diseases. We used a top-down approach for the cost associated with hospital care and a bottom-up approach to estimate the cost associated with outpatient and primary care. The current study was conducted from a provider perspective since the state bears the majority of the costs of screening and treatment in Swaziland. All identifiable direct medical costs were considered for cervical lesions, cervical cancer and genital warts, which were primary diagnoses during 2015. A mix of bottom up micro-costing ingredients approach and top-down approaches was used to collect data on costs. All costs were computed at the price level of 2015 and converted to dollars ($). RESULTS: The total annual estimated direct medical cost associated with screening, managing and treating cervical lesions, CC and genital warts in Swaziland was $16 million. The largest cost in the analysis was estimated for treatment of high-grade cervical lesions and cervical cancer representing 80% of the total cost ($12.6 million). Costs for screening only represented 5% of the total cost ($0.9 million). Treatment of genital warts represented 6% of the total cost ($1million). CONCLUSION: According to the cost estimations in this study, the economic burden of HPV-related cervical diseases and genital warts represents a major public health issue in Swaziland. Prevention of HPV infection with a national HPV immunization programme for pre-adolescent girls would prevent the majority of CC related deaths and associated costs.
format Online
Article
Text
id pubmed-5439687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54396872017-06-06 Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland Ginindza, Themba G. Sartorius, Benn Dlamini, Xolisile Östensson, Ellinor PLoS One Research Article BACKGROUND: Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland. Cost analysis is critical in providing useful information for economic evaluations to guide policymakers concerned with the allocation of resources in order to reduce the disease burden. MATERIALS AND METHODS: A prevalence-based cost of illness (COI) methodology was used to investigate the economic burden of HPV-related diseases. We used a top-down approach for the cost associated with hospital care and a bottom-up approach to estimate the cost associated with outpatient and primary care. The current study was conducted from a provider perspective since the state bears the majority of the costs of screening and treatment in Swaziland. All identifiable direct medical costs were considered for cervical lesions, cervical cancer and genital warts, which were primary diagnoses during 2015. A mix of bottom up micro-costing ingredients approach and top-down approaches was used to collect data on costs. All costs were computed at the price level of 2015 and converted to dollars ($). RESULTS: The total annual estimated direct medical cost associated with screening, managing and treating cervical lesions, CC and genital warts in Swaziland was $16 million. The largest cost in the analysis was estimated for treatment of high-grade cervical lesions and cervical cancer representing 80% of the total cost ($12.6 million). Costs for screening only represented 5% of the total cost ($0.9 million). Treatment of genital warts represented 6% of the total cost ($1million). CONCLUSION: According to the cost estimations in this study, the economic burden of HPV-related cervical diseases and genital warts represents a major public health issue in Swaziland. Prevention of HPV infection with a national HPV immunization programme for pre-adolescent girls would prevent the majority of CC related deaths and associated costs. Public Library of Science 2017-05-22 /pmc/articles/PMC5439687/ /pubmed/28531205 http://dx.doi.org/10.1371/journal.pone.0177762 Text en © 2017 Ginindza et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ginindza, Themba G.
Sartorius, Benn
Dlamini, Xolisile
Östensson, Ellinor
Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title_full Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title_fullStr Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title_full_unstemmed Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title_short Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
title_sort cost analysis of human papillomavirus-related cervical diseases and genital warts in swaziland
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439687/
https://www.ncbi.nlm.nih.gov/pubmed/28531205
http://dx.doi.org/10.1371/journal.pone.0177762
work_keys_str_mv AT ginindzathembag costanalysisofhumanpapillomavirusrelatedcervicaldiseasesandgenitalwartsinswaziland
AT sartoriusbenn costanalysisofhumanpapillomavirusrelatedcervicaldiseasesandgenitalwartsinswaziland
AT dlaminixolisile costanalysisofhumanpapillomavirusrelatedcervicaldiseasesandgenitalwartsinswaziland
AT ostenssonellinor costanalysisofhumanpapillomavirusrelatedcervicaldiseasesandgenitalwartsinswaziland